Morgan Stanley sees 35% upside for Amazon stock, here’s why
Morgan Stanley revised its outlook on Amazon after tariffs between the US and China came to a reasonable level. The brokerage maintained…
European stocks soar higher on hopes of trade deal: FTSE up 0.8%, DAX jumps 0.4%
European stocks advanced on Thursday as investors looked for signs of progress in trade talks between the United States and the European…
Freeport-McMoRan shares rise on Trump’s 50% copper tariffs: why is it a ‘top pick’
Shares of US-based copper giant Freeport-McMoRan climbed 3.75% to $47.30 in premarket trading on Wednesday, as investors reacted to a new 50%…
UBS raises global oil refining margins outlook amid delays and closures
UBS announced a revised outlook on the global oil refining industry, anticipating a significant tightening of supply balances in the coming years. …
Pudgy Penguins jumps 23% on ETF proposal linking crypto and NFT assets
Pudgy Penguins (PENGU) surged 23.54% to $0.018 on July 9, marking its highest value since January 2025. The rally followed a key…
India’s cybercrime crisis: scammers prey on dreams in the age of Digital India
By Sarthak Goswami Priyanka, a night-shift worker from Ghaziabad, epitomises the aspirations of many Indians who have embraced the digital revolution. Working…
Asia markets mixed as Trump expands tariffs: Hang Seng slumps 1%, Nikkei extends gains
Asian markets ended mixed on Wednesday after US President Donald Trump escalated trade tensions with steep new tariffs targeting copper, semiconductors, and…
Reliance delays Jio IPO: here’s why the $100 billion giant is holding back
Billionaire Mukesh Ambani-led Reliance Jio Platforms has opted to postpone its highly anticipated initial public offering (IPO), shelving plans for a 2025…
Goldman Sachs demands loyalty oath as Wall Street war for young talent escalates
The race to attract and keep young talent in the financial world is getting more intense than ever. In response, major investment…
Verona Pharma shares jump with Merck set to acquire company in $10 billion deal
Merck announced Wednesday it will acquire UK-based Verona Pharma for approximately $10 billion, deepening its commitment to respiratory treatments as the company…
